IL-10 downregulates MHC-II and CD86 surface expression on dendritic cells and macrophages, impairing their antigen-presenting capacity to CD4+ T cells, thereby attenuating inflammatory responses in RA (51). The gene discussed is CD4; the disease is rheumatoid arthritis.